Amphastar Pharmaceuticals Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (34)

Latest Posts

About This Stock More About This Stock
Revance, Amphastar Named Top 2020 Specialty Pharmaceuticals Ideas At Wells Fargo
Article By: The Fly
Wednesday, January 22, 2020 8:21 AM EDT
Wells Fargo analyst Jacob Hughes named Revance Therapeutics and Amphastar Pharmaceuticals his top ideas for 2020 in the Specialty Pharmaceuticals space.
In this article: AMPH, RVNC Also: AGN, EBS, JAZZ, PRGO, TEVA, MNK, BHC, OSMT, KRTX
Read
Cempra Plunges To 52-Week Low, Shire Drug Label Expanded
Article By: Arpita Dutt
Friday, December 30, 2016 10:33 AM EDT
It was a relatively slow week for pharma stocks though a couple of companies suffered regulatory setbacks with the FDA issuing complete response letters (CRLs) for their regulatory applications.
In this article: AMPH, AZN, BMY, CEMP, MRK, MYL, SHPG
Read
Your Complete Guide To The Generic Drug Industry
Article By: Zacks Investment Research
Wednesday, August 31, 2016 12:00 AM EDT
With some diseases, the range of safe concentration levels is incredibly narrow, which could make switching from name-brand to generic dangerous. But most generics are safe, and cheaper.
In this article: AGN, NVS, AKRX, MYL, PRGO, TEVA, AXGN, AMPH, GNRX
Read
Amphastar Pharmaceuticals - Chart Of The Day
Article By: Jim Van Meerten
Thursday, March 5, 2015 5:58 PM EDT
Earnings estimated to compound at an annual rate of 5.00% for the next 5 years.
In this article: AMPH
Read
What This Upcoming Monday Means For MannKind Shareholders
Article By: Dr. Hung Tran
Monday, August 11, 2014 8:59 AM EDT
As MannKind Corporation (NASDAQ: MNKD) prepares to release its earnings report on Monday, August 11, both investors and short sellers wait in suspense.
In this article: MNKD, AMPH
Read

PARTNER HEADLINES

Latest Tweets for $AMPH

No tweets yet!